Search - tctmd.com

Displaying 261 - 280 of 650

Sort: Relevancy | Date

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

News Daily News

MitraClip Viable in Shock Patients With Significant MR: Observational Study

Michael O'Riordan

July 29, 2021

News Conference News SCCT 2021

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Yael L. Maxwell

July 20, 2021

News Daily News

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

Michael O'Riordan

July 01, 2021

News Daily News

OMT Boosts Survival in Revascularized Patients at 10 Years

Michael O'Riordan

June 29, 2021

News Daily News

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

L.A. McKeown

June 16, 2021

News Conference News EAS 2021

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

Michael O'Riordan

June 08, 2021

News Conference News EAS 2021

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

Michael O'Riordan

June 03, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2021

Shelley Wood

May 31, 2021

News Conference News ACC 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

L.A. McKeown

May 21, 2021

News Conference News EuroPCR 2021

Elective Revascularization, Better Long-term Survival: Meta-analysis

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

Michael O'Riordan

May 18, 2021

News Conference News ACC 2021

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

Michael O'Riordan

May 15, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

L.A. McKeown

April 26, 2021

News Daily News

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

Michael O'Riordan

April 12, 2021

News Opinion CV Team Dispatch

April 2021 News Roundup

L.A. McKeown

April 10, 2021

News Daily News

LITE: High- Beats Low-Intensity Exercise at Home for Improving PAD

L.A. McKeown

April 09, 2021

Advertisement

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

PAD Continues to Elude Clinicians, Despite Gains: AHA

MitraClip Viable in Shock Patients With Significant MR: Observational Study

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Big Downturn in CVD Procedures Seen During COVID-19’s First Wave

OMT Boosts Survival in Revascularized Patients at 10 Years

First PCIs Preceded by Many Modifiable Risk Factors: Registry Data

High Ischemic Risk and Bleeding Risk: A Delicate Balance Post-PCI

For High-Risk Patients Getting Evolocumab in Europe, Other Meds Fall Short

TCTMD’s Top 10 Most Popular Stories for May 2021

Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions

Elective Revascularization, Better Long-term Survival: Meta-analysis

Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’

High- and Low-Dose Aspirin Equivalent in ASCVD: ADAPTABLE

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Critical Limb Ischemia During COVID: Lessons for Care and Clinical Trials

Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI

April 2021 News Roundup

LITE: High- Beats Low-Intensity Exercise at Home for Improving PAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content